News | Radiation Therapy | September 07, 2016

ASTRO Announces Featured Clinical Trials and Research for 2016 Annual Meeting

Press program will highlight innovations in cancer care from 15 leading studies in five news briefings held live on-site and via webcast

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy

September 7, 2016 — The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept. 25-28 in Boston. The program includes multiple reports from phase III clinical trials, researchers from leading institutions in the United States and abroad, and examinations of a range of cancer types and patient populations. Researchers will share their findings in a series of briefings held on-site at the Boston Convention & Exhibition Center and webcast to registered press.

The news briefing schedule is as follows:

Meeting Overview & Report on ASTRO Initiatives

  • Sunday, Sept. 25, 2:45 - 3:15 p.m. ET
  • Features David C. Beyer, M.D., FASTRO, current president and incoming chair of ASTRO

Refining Treatment Decisions

  • Monday, Sept. 26, 8:00 - 9:00 a.m. ET
  • Features studies evaluating conventional versus accelerated treatment approaches for brain metastases, lung cancer and prostate cancer

Expanding Access to Care

  • Monday, Sept. 26, 10:30 - 11:30 a.m. ET
  • Features studies on expanding care to overlooked or growing patient populations, including elderly patients, African Americans, developing countries and veterans

Advances in Prostate Cancer Care

  • Tuesday, Sept. 27, 8:00 - 9:00 a.m. ET
  • Features large trials and multi-institution studies examining treatment advances in brachytherapy, teletherapy and biomarker subtyping for prostate cancer

Innovations in RT Delivery

  • Tuesday, Sept. 27, 1:30 p.m. - 2:30 p.m. ET
  • Features reports of how new approaches to radiation therapy delivery impact disease control and quality of life for gynecologic, breast and pediatric brain cancers

 

The 2016 ASTRO Annual Meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. The meeting will feature abstracts, scientific and educational presentations on radiation oncology clinical trials and research, and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization and a top safety executive from Delta Air Lines.

Led by Beyer, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based health care. Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org

Related Content

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Check-Cap Initiates U.S. Pilot Study of C-Scan for Colorectal Cancer Screening
News | Colonoscopy Systems | April 15, 2019
Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Deep Lens Closes Series A Financing for Digital AI Pathology Platform
News | Digital Pathology | April 09, 2019
Digital pathology company Deep Lens Inc. announced the closing of a $14 million Series A financing that will further...
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...